Stockman Wealth Management Inc. Has $388,000 Holdings in SPDR S&P Biotech ETF (XBI)

Stockman Wealth Management Inc. cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,280 shares of the exchange traded fund’s stock after selling 600 shares during the period. Stockman Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $388,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of XBI. Cranbrook Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $26,000. Gradient Investments LLC purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $27,000. Truewealth LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Quattro Financial Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 49.6% in the 4th quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock valued at $31,000 after purchasing an additional 124 shares in the last quarter. Finally, Lehman & Derafelo Financial Resources LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $32,000.

XBI traded down $0.56 during trading on Friday, reaching $82.93. The company’s stock had a trading volume of 263,545 shares, compared to its average volume of 5,061,270. SPDR S&P Biotech ETF has a 52-week low of $64.38 and a 52-week high of $101.55.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Stock Observer and is the sole property of of Stock Observer. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.thestockobserver.com/2019/05/17/stockman-wealth-management-inc-has-388000-holdings-in-spdr-sp-biotech-etf-xbi.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: What is the Producer Price Index (PPI)?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.